The Peptide Report
Across Silicon Valley, the 3pm espresso is quietly being replaced. The new performance lever isn't another stimulant — it's cellular energy itself.
Across Silicon Valley, a quiet shift is underway: the highest performers are walking away from third espressos and nootropic stacks. What they're reaching for instead targets energy at its actual source — the mitochondria.
The 3 PM crash isn't a coffee problem — it's a cellular energy problem. Here's why high-performers are quietly switching from their third espresso to a doctor-formulated NAD+ nasal spray.
The 3 PM energy crash isn't a productivity problem — it's a cellular one. Here's why high-performers are quietly turning to mitochondrial support instead of another espresso.
The afternoon crash isn't a caffeine deficiency — it's a cellular one. Inside the quiet shift among Silicon Valley executives toward intranasal NAD+ as a sustainable answer to mid-day fatigue.
A quiet shift is underway in Silicon Valley morning routines: caffeine is out, mitochondrial support is in. Inside the rise of NAD+ nasal sprays and the biohacking protocol redefining peak performance.
